Struggling drugmaker Valeant (VRX) explodes for 13% gains Thursday >>> READ MORE

MORN

Recent Articles

7 Large-Cap Stocks That Should Go Private

Private equity firms have never had so much capital to invest. These seven large-cap stocks should go private for their investors' sake. More 

7 Blue-Chip Stocks You Should Kick to the Curb

The following seven blue-chip stocks look like sells right now for a number of reasons, whether it's sky-high valuation or slowing growth. More 

10 Capital Markets Stocks to Sell Now

This week, the ratings of 10 Capital Markets stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

8 Capital Markets Stocks to Sell Now

This week, the ratings of 8 Capital Markets stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

6 Capital Markets Stocks to Sell Now

This week, the overall grades of 6 Capital Markets stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

16 Capital Markets Stocks to Sell Now

The ratings of 16 Capital Markets stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

12 Capital Markets Stocks to Sell Now

This week, the ratings of 12 Capital Markets stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More